Table 2.
Univariate and multivariate logistic regression.
| Rebleeding within 6 weeks | Rebleeding within 1 year | |||||||
|---|---|---|---|---|---|---|---|---|
| Univariate analysis | Multivariate analysis | Univariate analysis | Multivariate analysis | |||||
| OR (95% CI) | P value | OR (95% CI) | P value | OR (95% CI) | P value | OR (95% CI) | P value | |
| Age | 0.989 (0.956–1.023) | 0.541 | 0.983 (0.962–1.005) | 0.129 | ||||
| Gender | 0.666 (0.236–1.879) | 0.442 | 0.869 (0.483–1.663) | 0.728 | ||||
| BMI | 1.029 (0.893–1.186) | 0.691 | 1.082 (0.988–1.184) | 0.088 | 1.146 (1.031–1.273) | 0.011 | ||
| Baseline LSM | 1.038 (0.998–1.078) | 0.060 | 1.041 (1.014–1.070) | 0.003 | 1.042 (1.011–1.075) | 0.008 | ||
| Portal vein diameter | 5.931 (1.397–25.191) | 0.016 | 3.020 (1.120–8.149) | 0.029 | ||||
| PTV | 1.203 (0.336–4.314) | 0.777 | 1.553 (0.701–3.440) | 0.278 | ||||
| Using NSBB drugs | 0.184 (0.069–0.492) | 0.010 | 0.170 (0.062–0.470) | 0.01 | 0.320 (0.179–0.572) | <0.001 | 0.274 (0.127–0.482) | <0.001 |
| Hemoglobin | 0.979 (0.962–0.997) | 0.024 | 0.979 (0.960–0.998) | 0.029 | 0.980 (0.969–0.991) | 0.001 | 0.976 (0.963–0.998) | <0.001 |
| White blood count | 0.856 (0.678–1.080) | 0.190 | 0.780 (0.999–0.913) | 0.002 | ||||
| Platelet count | 0.982 (0.968–0.996) | 0.010 | 0.985 (0.971–0.999) | 0.032 | 0.987 (0.981–0.994) | <0.001 | 0.989 (0.982–0.996) | <0.001 |
| PT | 1.029 (0.942–1.124) | 0.523 | 1.020 (0.949–1.096) | 0.597 | ||||
| Albumin | 0.998 (0.927–1.074) | 0.952 | 1.005 (0.959–1.053) | 0.825 | ||||
| TBIL | 1.001 (0.980–1.023) | 0.926 | 1.000 (0.986–1.014) | 0.992 | ||||
| ALT | 1.002 (0.995–1.009) | 0.561 | 0.999 (0.993–1.005) | 0.752 | ||||
| AST | 1.002 (0.996–1.007) | 0.580 | 0.999 (0.994–1.004) | 0.67 | ||||
| ALP | 0.989 (0.977–1.000) | 0.059 | 0.997 (0.994–1.001) | 0.129 | ||||
| GGT | 0.992 (0.982–1.003) | 0.157 | 0.998 (0.995–1.001) | 0.109 | ||||
| BUN | 0.980 (0.870–1.105) | 0.745 | 0.989 (0.929–1.054) | 0.734 | ||||
| Creatinine | 0.996 (0.978–1.015) | 0.698 | 0.989 (0.975–1.003) | 0.137 | ||||
| Sodium | 1.019 (0.950–1.093) | 0.604 | 1.001 (0.981–1.022) | 0.898 | ||||
| Potassium | 0.974 (0.844–1.125) | 0.724 | 0.999 (0.981–1.018) | 0.915 | ||||
| Triglycerides | 0.848 (0.363–1.985) | 0.704 | 0.984 (0.609–1.590) | 0.946 | ||||
| Cholesterol | 0.592 (0.345–0.989) | 0.045 | 0.841 (0.650–1.089) | 0.189 | ||||
| HDL | 0.697 (0.249–1.956) | 0.493 | 1.024 (0.574–1.916) | 0.941 | ||||
| LDL | 0.546 (0.228–1.107) | 0.096 | 0.754 (0.525–1.092) | 0.136 | ||||
| HBeAg | 0.305 (0.400–2.345) | 0.254 | 1.158 (0.516–2.598) | 0.722 | ||||
All variables were entered in a forward LR elimination procedure with a P value to exit set at >0.10. Empty cells refer to the variables excluded from the multivariable-adjusted logistic regression models. BMI: body mass index; baseline LSM: baseline liver stiffness measurements; PVT: portal vein thrombosis; NSBB: nonselective beta-blockers; PT: prothrombin time; TBIL: total bilirubin; ALT: alanine aminotransferase; AST: aspartate aminotransferase; ALP: alkaline phosphatase; GGT: glutamyl transpeptidase; BUN: blood urea nitrogen; HDL: high-density lipoprotein; LDL: low-density lipoprotein; HBeAg: hepatitis B virus e antigen; MELD: model for end-stage liver disease.